Chlorofair From Pharmafair With Chloramphenicol 1% Information for Drugs and Acne

The Ingredients: Chloramphenicol
Dosage Form and Administration: Ointment; Ophthalmic
Drug Trade Name: Chlorofair
Firm: Pharmafair
Strength: 1%
New Drug Application Type: A
The Drug Application Number:62439
Medicine Product Number: 1
Approval Date: 4/21/1983
Reference Listed Drug: No
Type: DISCN
Applicant Full Name: Pharmafair Inc

Rash

Rashes involve changes in the color or texture of the skin. Doctors can determine the cause of a rash from its visible characteristics and other symptoms. Dermatitis is the name of a simple rash and means inflammation of the skin. Contact dermatitis presents from things the skin touches, such as: dyes and other chemicals in clothing; chemicals in elastic, latex and rubber products; cosmetics, soaps and detergents; and poison ivy and oak.

Drug Addiction Affects Behavior

Drug addiction is a brain disease that affects behavior. Drug addiction has cognitive, behavioral and physiological characteristics that contribute to continued drugs use despite the harmful consequences. Scientists have found that chronic drug abuse alters the anatomy and chemistry of the brain and that these changes can last for months or years after the individual has stopped using drugs. This transformation may help explain why addicts are at a high risk of relapse to drug abuse even after long periods of abstinence and why addicts persist in seeking drugs despite deleterious consequences.

Treatment Helps Recovery

Recovery from drug addiction requires effective treatment, followed by management of the problem over time. Drug addiction is a serious problem that can be treated and managed throughout its course. Effective drug abuse treatment engages the participant in a therapeutic process, retains the user in treatment for an appropriate length of time and helps the addict learn to maintain abstinence over time. Addicts may require multiple episodes of treatment. Outcomes for drug abusing offenders in the community can be improved by monitoring drug use and by encouraging continued participation in treatment.